3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow GSK2881078: new trials by email Literature Review of GSK2881078 trials Research Report on GSK2881078
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) GSK2881078, Matching Placebo - Cachexia | Phase 2 | Completed | GlaxoSmithKline | 97 | 2018-02-28 | 2020-07-15 |
| Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078 GSK2881078, Placebo, Itraconazole - Cachexia | Phase 1 | Completed | GlaxoSmithKline | 108 | 2015-09-01 | 2017-03-06 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses GSK2881078, Placebo - Cachexia | Phase 1 | Completed | GlaxoSmithKline | 99 | 2014-01-20 | 2018-07-24 |
Cachexia (3) · Muscle Weakness (1) · Pulmonary Disease, Chronic Obstructive (1)
GlaxoSmithKline (3)
United States (3) · Germany (1) · United Kingdom (1)
2017 (1)